US › Healthcare

Microbot Medical Inc (MBOT)

US · Healthcare · Medical Devices

$1.82+2.82%
Last close · 2026-08-04

Latest quarter · ended 2026-03-31

Revenue
$105,000
Net profit
$-3.7M
Profit YoY
-41.1%
EPS
$-0.05
EPS estimate
$-0.08
Net margin
-3,496.2%

EPS came in at -0.05 against a street estimate of -0.08 — a beat of 37.5%.

Key statistics

Market cap
$118.9M
Forward P/E
18.3
P/B
1.56
Book value
$1.10
EPS (TTM)
$-0.26
52-week high
$4.67
52-week low
$1.60
50-day MA
$1.83
200-day MA
$2.13
Beta
1.05

Analyst view

Analysts rate Microbot Medical Inc a buy (1 buy, 0 hold, 0 sell out of 1) with an average price target of $7.00.

Shareholding

Institutions
21.88%

Largest institutional holders

FundStake
Vanguard Group Inc4.96%
Vanguard Capital Management, LLC4.33%
CIBC Bancorp USA Inc.2.78%
Atlantic Trust Group, LLC2.20%
Susquehanna International Group, LLP1.38%
BlackRock Inc1.28%
UBS Group AG1.22%
Geode Capital Management, LLC1.13%

See the full picture

Technicals, trade setups with a published hit rate, $AI analysis and earnings-call summaries for Microbot Medical Inc — free to start.

Google PlayApp Store

Other Healthcare companies

Eli Lilly and CompanyJohnson & JohnsonAbbVie IncUnitedHealth Group IncorporatedMerck & Company IncNovartis AG ADRAstraZeneca PLCThermo Fisher Scientific IncNovo Nordisk A/SAmgen IncAbbott LaboratoriesGilead Sciences Inc

Data updated 2026-08-05.